沙菲纳米德对帕金森病患者报告结果的影响
相关实验视频
Updated: Jul 13, 2025

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.5K
Christian Espinoza-Vinces1, Rafael Villino-Rodríguez1, Ainhoa Atorrasagasti-Villar1
1Department of Neurology, Clínica Universidad de Navarra, Pamplona, Spain.
Patient related outcome measures
|October 16, 2023
概括
沙菲纳胺有效地改善了帕金森病 (PD) 患者的生活质量,通过减少衰弱的非运动症状 (NMS). 这种MAOB-I提供了一个有前途的治疗选择,用于管理超出运动控制的PD.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 帕金森病 (PD) 涉及阴极多巴胺基细胞退化,导致运动和非运动症状 (NMS),损害生活质量 (QoL).
- NMS显著影响QoL,并且难以管理,因为它们对多巴胺替代疗法没有反应.
- 萨菲纳米德是一种单氨酸氧化酶B型抑制剂 (MAOB-I),是PD患者的有效补充治疗,用于治疗PD患者的乐伏多巴.
研究的目的:
- 评估沙菲纳胺对患者报告结果的影响,特别关注帕金森病 (PD) 的非运动症状 (NMS) 和生活质量 (QoL).
- 探索萨菲纳米德在管理超出运动控制范围的更广泛的PD症状的疗效.
主要方法:
- 在PubMed上对2018年至2023年间发表的研究进行了全面的文献搜索.
- 纳入标准集中在临床试验,随机对照试验,系统性审查,元分析和评论.
- 搜索策略使用了MeSH术语,这些术语与萨菲纳米德及其对PD的QoL的影响有关.
主要成果:
- 沙菲纳胺对PD患者的QoL产生了显著的积极影响.
- 这种药物有望缓解各种NMS,包括疲劳,疼痛,情绪障碍和睡眠问题.
- 来自临床试验和现实世界的数据的证据支持safinamide对运动和非运动症状的好处.
结论:
- 沙菲纳胺在帕金森病患者中显著改善了QoL.
- 这项研究支持safinamide在减轻使NMS失效的负担中的作用.
- 沙菲纳胺为全面的PD管理提供了有价值的治疗选择.
相关概念视频
Parkinson's Disease: Treatment
283
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
283
Parkinson's Disease: Overview
579
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
579
Drug Therapy
49
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
49
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
173
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
173
Pharmacovigilance
863
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
863
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K

